• What Are Peptides? A Plain-English Guide to Research Peptides

    The short version: Peptides are short chains of amino acids, typically between 2 and 50 units long, that occur naturally in the body and can also be synthesized in a laboratory. They differ from proteins in size and structure, and they differ from steroids in origin and mechanism. Research peptides are synthetic versions sold for laboratory use only, not for human consumption. Alta Peptides publishes lot-specific certificates of analysis for every product configuration, which is the baseline standard any researcher should expect before ordering.

    Search for “what are peptides” and you will find a range of explanations that either oversimplify the science or blur the line between naturally occurring compounds and the research chemicals sold online. The word peptide gets applied to compounds with very different origins, mechanisms, and regulatory statuses, which makes it difficult to know what any given product actually is.

    This guide is written for laboratory researchers and curious readers who want a clear explanation of what peptides are, how they differ from proteins and steroids, how they are studied, and what the research-use-only label actually means.

    What a peptide is, chemically

    A peptide is a chain of amino acids linked by peptide bonds. Amino acids are the building blocks of proteins, and the same 20 standard amino acids that make up human proteins also make up peptides. The difference is length. A peptide typically contains between 2 and 50 amino acids. A protein contains more than 50, often hundreds or thousands.

    The distinction matters because size affects how a molecule behaves in the body. A review published in the journal Biomedicines explains that peptides are generally smaller, more mobile, and more easily synthesized than full proteins, which makes them attractive as research tools and therapeutic candidates. Their smaller size also means they can sometimes penetrate tissues that larger proteins cannot.

    Peptides are classified in several ways. By origin, they can be endogenous, meaning produced naturally in the body, or synthetic, meaning manufactured in a laboratory. By function, they can be hormones, neurotransmitters, growth factors, or antimicrobial agents. By length, they range from dipeptides with two amino acids to longer chains that approach protein scale. A review in the journal Pharmaceutics describes how these classifications overlap, and how the same peptide can be studied in multiple research contexts.

    Peptides versus proteins versus steroids

    The terms peptide, protein, and steroid are often used loosely in marketing, but they describe different classes of molecules with different structures and different regulatory frameworks.

    A protein is a large molecule made of one or more long chains of amino acids. Proteins perform most of the work in cells, from catalyzing reactions to transporting molecules to providing structure. A peptide is a shorter version of the same basic chemistry.

    A steroid is a completely different class of molecule. Steroids are lipids with a characteristic four-ring structure derived from cholesterol. They include hormones like testosterone, cortisol, and estrogen. The American Medical Association’s guidance on injectable peptides notes that peptides and steroids are often confused because both can be sold as injectables, but their chemistry, their mechanisms, and their regulatory status are different.

    Anabolic steroids are regulated as controlled substances in many jurisdictions, including the United States and the United Kingdom. Research peptides are regulated differently, typically sold under a research-use-only designation that restricts them to laboratory use. The two categories are not interchangeable, and a supplier that conflates them is either misinformed or misrepresenting the product.

    How peptides are studied in research

    Peptides are studied across a wide range of disciplines, from endocrinology to immunology to neuroscience. The research context depends on what the peptide does and how it interacts with biological systems.

    Some peptides are studied as hormones. Insulin, glucagon, and growth hormone-releasing hormone are examples of naturally occurring peptides that regulate metabolism and growth. Synthetic analogs of these peptides are used in medicine, and research-grade versions are used in laboratory work.

    Some peptides are studied for their antimicrobial properties. Defensins and cathelicidins are naturally occurring peptides that form part of the innate immune system. Researchers study their mechanisms to understand how the body defends against infection, and synthetic versions are investigated for potential applications.

    Some peptides are studied as signaling molecules. Neuropeptides like substance P and neuropeptide Y regulate pain, mood, and appetite. Researchers study their receptors and pathways to understand how the nervous system communicates.

    The common thread is that peptides interact with specific receptors or pathways in ways that can be measured and studied. That is what makes them useful research tools. The Alta Peptides guide to peptides explains that research-grade peptides are supplied as lyophilized powders that require reconstitution before laboratory use, and that the certificate of analysis is the document that establishes identity, purity, and content.

    Video: Exposing the truth about peptides

    This third-party video provides general context on peptides. It is not affiliated with Alta Peptides and is not a substitute for laboratory documentation or the published literature.

    What the research-use-only label means

    Most peptides sold online are labeled for research use only. The research-use-only (RUO) designation is a legal boundary, not a marketing suggestion. It means the product is intended for laboratory research and is not approved for diagnostic, therapeutic, or human use.

    The FDA’s guidance on products labeled for research use only explains that the RUO designation is intended for products used in laboratory research settings. The guidance also notes that the label does not exempt a product from regulation if the seller’s own marketing establishes an intended human use.

    What that means in practice is that a supplier can sell research peptides and publish analytical documentation without crossing into human-use marketing. When a supplier stays on the research side of that line, the certificate of analysis becomes the primary basis for evaluating the product. When a supplier crosses the line, the documentation is no longer the main thing being sold.

    The Alta Peptides guide to peptide legality in the UK explains that research peptides occupy a different regulatory space from licensed medicines, and that the RUO designation is the boundary that separates the two.

    Common misconceptions about peptides

    Several misconceptions circulate about peptides, and researchers benefit from understanding what the evidence does and does not support.

    Misconception: peptides are steroids

    Peptides and steroids are different classes of molecules with different chemistry. Steroids are lipids with a four-ring structure. Peptides are chains of amino acids. Some steroids are controlled substances. Research peptides are not. Conflating the two leads to confused regulation and confused marketing.

    Misconception: peptides are all natural

    Some peptides are naturally occurring. Insulin, for example, is a peptide hormone produced by the pancreas. Other peptides are entirely synthetic, designed in a laboratory to interact with specific receptors. The word peptide describes a chemical structure, not an origin. A peptide can be natural, synthetic, or a synthetic version of a natural sequence.

    Misconception: research-grade means safe for human use

    Research-grade means the product meets analytical specifications for laboratory work. It does not mean the product has been evaluated for safety in humans. The AMA guidance on injectable peptides notes that peptides sold for research use have not undergone the clinical testing required for FDA approval, and that their safety and efficacy in humans are unknown.

    Misconception: all peptides work the same way

    Peptides interact with different receptors and pathways. Some bind to cell surface receptors. Some act inside cells. Some are hormones, some are neurotransmitters, some are antimicrobial agents. The mechanism depends on the specific peptide. A finding about one peptide does not apply to another.

    How to evaluate a research peptide supplier

    For researchers who need material that will hold up in a laboratory context, the documentation is the starting point. Here is what to check.

    Lot-specific certificate of analysis. The COA should correspond to the exact lot you are buying, not a generic sample. It should list the lot number, the testing laboratory, the report ID, the date the sample was received, and the date the results were published.

    Complete analytical panel. A certificate that lists only a purity percentage is incomplete. The useful fields are identity by mass spectrometry, purity by HPLC, measured content, endotoxin, and sterility.

    Named independent laboratory. The testing laboratory should be identified and should be a different organization from the supplier. A report produced in-house does not provide the same level of assurance as a third-party report.

    Research-use-only boundary. The listing should not publish dosing, administration, or human-use content. If it does, the RUO label is not being maintained in good faith.

    The Alta Peptides guide to reading a certificate of analysis walks through each field and explains what a complete report should contain.

    Comparing peptide categories

    The table below outlines the main categories of peptides and how they differ.

    Category Origin Example Research context
    Hormone peptides Natural or synthetic analog Insulin, GHRH analogs Metabolism, growth, endocrine function
    Neuropeptides Natural Substance P, NPY Pain, mood, appetite signaling
    Antimicrobial peptides Natural Defensins, cathelicidins Innate immunity, infection defense
    Growth factor peptides Natural or synthetic GHK-Cu, TB-500 Tissue repair, cell migration
    Synthetic research peptides Laboratory synthesis BPC-157, MOTS-c Varies by compound

    How Alta Peptides approaches documentation

    Alta Peptides is a UK-based research peptide supplier that publishes lot-specific documentation for each product configuration. The company’s certificates page collects the reports for all products so that researchers can compare documentation across configurations. The journal publishes educational content on peptide handling, storage, and certificate interpretation.

    The product pages show the current lot report alongside the price, and the company maintains a research-use-only boundary throughout its product descriptions. For researchers who need to verify a supplier before ordering, the relevant questions are whether the documentation is specific to the lot, whether the testing laboratory is named, and whether the results can be independently reviewed.

    Common questions about peptides

    What is the difference between a peptide and a protein?

    Both are chains of amino acids. The difference is length. A peptide typically contains between 2 and 50 amino acids. A protein contains more than 50, often hundreds or thousands. The distinction is a convention rather than a sharp boundary, but it affects how the molecule behaves and how it is studied.

    Are peptides steroids?

    No. Peptides are chains of amino acids. Steroids are lipids with a four-ring structure derived from cholesterol. The two classes are chemically different, and they are regulated differently. Some steroids are controlled substances. Research peptides are not.

    Are research peptides safe for human use?

    Research peptides are sold for laboratory use only. They have not been evaluated for safety or efficacy in humans through the clinical trial process required for FDA approval. The research-use-only label is a legal boundary, not a statement about safety. The AMA guidance on injectable peptides notes that the safety of these compounds in humans is often unknown.

    What should a peptide certificate of analysis include?

    A complete COA should report identity by mass spectrometry, purity by HPLC with the method stated, measured content or assay value, endotoxin testing, and sterility testing. It should also include the lot number, the testing laboratory’s name, the report ID, and the dates of sample receipt and result reporting.

    How do I verify that a COA is authentic?

    Check that the testing laboratory is named and that the report ID can be cross-referenced. Some laboratories publish verification portals where a report ID can be entered to confirm the document’s authenticity. If the supplier cannot identify which laboratory performed the test, the certificate cannot be independently verified.

    What does research-use-only mean?

    The RUO designation means the product is intended for laboratory research and is not approved for diagnostic, therapeutic, or human use. It is a legal boundary that separates research chemicals from medical products. A supplier that maintains the boundary consistently is easier to trust than one that publishes human-use content alongside the RUO label.

    Important notice: This article is provided for educational and informational purposes only. It does not constitute medical, legal, or regulatory advice. Research peptides discussed here are sold exclusively for laboratory research use and are not approved by the FDA, the MHRA, or any other regulatory agency for human or veterinary use. Nothing in this article should be construed as guidance for human consumption, dosing, or administration. Statements regarding dietary supplements and research compounds have not been evaluated by the FDA. Researchers are responsible for complying with all applicable laws and regulations in their jurisdiction. Always consult the product label, the certificate of analysis, and a qualified professional before making decisions about any substance.

  • Retatrutide for Sale: What Researchers Should Verify Before Ordering

    Quick answer: Retatrutide is an investigational triple agonist that has not been approved by any regulatory agency. Vials sold online are labeled for laboratory research only, not human use. Before ordering, verify the supplier’s third-party certificate of analysis, confirm the exact lot number, and understand that the FDA has issued repeated warning letters to sellers marketing this peptide for human consumption. Stack Research publishes lot-specific COAs for every batch, which is the baseline standard any researcher should expect.

    If you type “retatrutide for sale” into a search engine, you will find dozens of storefronts offering vials with prices that range from $80 to $500. Some sites look polished. Some show certificates of analysis. A few even include third-party testing data. The problem is that the phrase itself does not tell you what you are actually buying, whether the vial contains what the label says, or whether the seller has any documentation to back up their claims.

    This guide is written for laboratory researchers who need to evaluate a retatrutide supplier before placing an order. It covers what the published literature actually says about the compound, what the FDA has done about the online market, how to read a certificate of analysis without getting fooled by formatting, and what questions separate a transparent supplier from one that is hoping you will not ask.

    What retatrutide is, and what it is not

    Retatrutide is a synthetic peptide that acts as an agonist at three receptors: glucagon, glucose-dependent insulinotropic polypeptide (GIP), and glucagon-like peptide-1 (GLP-1). The discovery literature refers to it as LY3437943. Researchers study it because the triple mechanism produces effects that differ from single-agonist or dual-agonist peptides, and the published trial data has drawn significant attention.

    In the TRIUMPH-1 Phase 3 trial, participants taking 12 mg of retatrutide lost an average of 70.3 pounds, or 28.3 percent of their body weight, over 80 weeks. The same trial reported that 45.3 percent of participants in the 12 mg group achieved at least 30 percent weight loss, a threshold historically associated with bariatric surgery. Eli Lilly’s published trial results describe these outcomes in detail, and the figures are consistent with earlier Phase 2 data.

    What retatrutide is not, at least as of this writing, is an approved medicine. It has not received authorization from the FDA, the European Medicines Agency, or any other national regulatory body. Reporting from BBC Science Focus quotes the manufacturer stating that retatrutide “has not been approved by any regulatory agency and is legally available only through Lilly’s clinical trials.” Anything sold to consumers outside of a trial setting is, in the manufacturer’s own words, illegal, with no way to verify its safety, purity, or dosing.

    That distinction matters for researchers. A vial labeled “retatrutide” and sold for laboratory research is not the same product as the clinical trial material. The trial material is manufactured under pharmaceutical-grade controls and administered under medical supervision. The research vial is a chemical reference sample. The two share a name and a mechanism, but they are not interchangeable, and no supplier should imply otherwise.

    Why the online market exists, and what the FDA has done about it

    The gap between trial access and public demand created a market. Public Citizen’s investigation into the peptide market found that since 2024 the FDA has sent 14 warning letters to companies selling retatrutide, yet as of May 2026, 11 of those 14 sellers continued to advertise the peptide, and eight continued to sell it outright. The report describes the situation as a regulatory failure in which enforcement has not kept pace with the volume of sellers entering the market.

    The FDA’s position is straightforward. In a warning letter to Prime Vitality, Inc., the agency stated that retatrutide products offered for sale are unapproved new drugs introduced into interstate commerce in violation of the Federal Food, Drug, and Cosmetic Act. The letter notes that even when a seller labels the product “for research purposes only” or “not for human consumption,” evidence on the seller’s own website, including testimonials, dosing guidance, and social media content, can establish that the product is intended for human use. When that happens, the research-use disclaimer does not protect the seller.

    The practical implication for researchers is that a supplier’s compliance posture is not just about the label on the vial. It is about the entire presentation: product descriptions, marketing copy, affiliate arrangements, and social media presence. A supplier that markets retatrutide through influencers who demonstrate injection techniques is not operating a research supply business, regardless of what the checkout page says.

    The verification checklist every researcher should run before ordering

    The difference between a defensible purchase and a gamble comes down to documentation. Here is what to check, in order.

    1. Lot-specific certificate of analysis, not a generic sample

    A certificate of analysis (COA) is only meaningful if it corresponds to the exact lot you are buying. A supplier that shows a single COA for “retatrutide” without tying it to a lot number is showing you marketing material, not a laboratory report. The COA should list the lot number, the testing laboratory, the report ID, the date the sample was received, and the date the results were published. If any of those fields are missing, the document cannot be used to verify the vial in your hand.

    Stack Research publishes a lot-specific report for each configuration of its GLP-3 (RT) research peptide. The current lot documentation shows HPLC purity of 99.9 percent, measured content of 10.37 mg, and passing results for bacterial endotoxin and sterility. The report identifies the testing laboratory as Accumark Labs and includes a report ID that can be cross-referenced. That level of specificity is the standard, not a bonus feature.

    2. What the COA actually tests

    A certificate that lists only “purity: 99%” is incomplete. The useful fields are identity, purity by HPLC, measured content, endotoxin, and sterility. Identity confirms the peptide sequence matches the reference standard. Purity by HPLC shows the percentage of the sample that is the target compound. Measured content tells you how much peptide is actually in the vial, which can differ from the label. Endotoxin and sterility results speak to the handling conditions, which matter for any research application where contamination would invalidate results.

    If a supplier’s COA omits measured content or endotoxin, that is a gap. It may not be a dealbreaker for every research context, but it is a data point about how thoroughly the supplier tests its material.

    3. The research-use-only boundary

    Every legitimate research peptide supplier uses the research-use-only (RUO) designation. The Stack Research research library explains how to read a certificate of analysis and how to compare purity against content, which are two different measurements. The RUO label means the product is not intended for diagnostic, therapeutic, or human use. It is a legal boundary, not a suggestion.

    What to watch for is a supplier that uses the RUO label while simultaneously publishing dosing information, before-and-after photos, or customer testimonials about human use. That combination is what the FDA has cited in warning letters. A supplier that maintains the boundary consistently is easier to trust because it is not trying to have it both ways.

    4. Pricing and configuration transparency

    Retatrutide vials are typically sold in 5 mg, 10 mg, and 30 mg configurations. The price per milligram should be calculable from the listing. If the listing obscures the vial size, bundles it with accessories, or requires a minimum order to see pricing, that is friction that makes comparison harder. Stack Research lists its 10 mg GLP-3 (RT) vial at $119.90 with volume pricing available to verified research accounts. The product page shows the exact SKU and lot information alongside the price, which makes the listing auditable.

    5. The regulatory context around the compound

    Researchers studying retatrutide should be aware that the FDA has placed certain bulk drug substances on a list of substances that may present significant safety risks when used in compounding. The FDA’s compounding safety page provides the current list and the reasoning behind each inclusion. This is not a restriction on laboratory research, but it is context that shapes how the compound is discussed in regulatory and clinical settings.

    The clinical trial record is also worth reviewing directly. ClinicalTrials.gov lists multiple active studies involving retatrutide, including trials for obesity, type 2 diabetes with renal impairment, and weight maintenance. Reading the trial protocols gives researchers a clearer picture of the dose ranges, endpoints, and safety monitoring that the clinical work involves. That context is useful when evaluating claims made by suppliers about what the compound “does.”

    Video: Why retatrutide draws research attention

    This video is a third-party explainer and is not affiliated with Stack Research. It provides general context on the compound’s mechanism and is not a substitute for the published literature or the product documentation.

    How Stack Research approaches retatrutide documentation

    Stack Research is a research peptide supplier that publishes lot-specific documentation for each product configuration. The company’s testing page describes the analytical methods used and the laboratories that perform the work. For researchers who need to verify a supplier before ordering, the relevant questions are whether the documentation is specific to the lot, whether the testing laboratory is named, and whether the results can be independently reviewed.

    The GLP-3 (RT) product page shows the current lot report directly on the page, with the purity, measured content, endotoxin, and sterility results visible without requiring a separate download. The COA library collects the reports for all products so that researchers can compare documentation across configurations. The company maintains a research-use-only boundary throughout its product descriptions and does not publish dosing or administration guidance.

    That last point is worth emphasizing because it is the dividing line the FDA has drawn in its enforcement actions. A supplier can sell research peptides and publish analytical documentation without crossing into human-use marketing. When a supplier stays on the research side of that line, the documentation becomes the primary basis for evaluating the product. When a supplier crosses the line, the documentation is no longer the main thing being sold.

    Comparing retatrutide documentation standards

    The table below outlines the documentation elements that separate a transparent listing from an incomplete one. It is not a ranking of suppliers but a framework for evaluating any listing you encounter.

    Documentation element What a complete listing shows Red flag if missing
    Lot-specific COA Report tied to the exact lot number, with testing lab named Generic COA or no lot number
    Identity test Confirms peptide sequence matches reference standard Purity percentage only, no identity result
    Measured content Actual peptide mass in the vial, not just label claim No fill or content verification
    Endotoxin and sterility Pass/fail results for both Omitted entirely
    Research-use-only boundary No dosing, administration, or human-use content Testimonials, before/after photos, influencer dosing content
    Price transparency Vial size, price, and SKU visible together Price hidden behind account creation or minimum order

    The table is not a guarantee. A supplier can produce all of these documents and still be selling a product that does not match the report, which is why independent testing services exist. But a supplier that cannot produce the documents at all is not worth the time it takes to evaluate further.

    Common questions researchers ask before ordering

    Is retatrutide legal to buy for research purposes?

    Retatrutide is not an approved drug, so it cannot be legally sold as a medicine. Research peptides labeled for laboratory use occupy a different regulatory space, but the FDA has made clear that the research-use label does not protect a seller who markets the product for human use. Researchers should purchase only from suppliers that maintain the research-use boundary and provide analytical documentation.

    What purity should a retatrutide COA show?

    Purity by HPLC above 95 percent is the typical threshold for research-grade peptides. Many suppliers report 98 to 99 percent or higher. The purity figure is only meaningful alongside identity and content results. A vial can be 99 percent pure and still contain less peptide than the label claims if the fill is off.

    How do I verify that a COA is real?

    Check that the testing laboratory is named and that the report ID can be cross-referenced. Some laboratories publish verification portals where a report ID can be entered to confirm the document’s authenticity. If a supplier cannot tell you which laboratory performed the test, the COA cannot be independently verified.

    What is the difference between retatrutide and GLP-3 (RT)?

    GLP-3 (RT) is the product name Stack Research uses for its retatrutide research peptide. The compound is the same. The naming convention reflects the triple-agonist mechanism: glucagon, GIP, and GLP-1. Researchers should confirm the identity of any product by its COA, not by the brand name on the vial.

    What should I do if a supplier’s listing makes health claims?

    Treat it as a disqualifying signal. Health claims on a research peptide listing are the exact pattern the FDA has cited in warning letters. A supplier that describes what the peptide “does” for the body is marketing an unapproved drug, regardless of the research-use label elsewhere on the page.

    Can I compare retatrutide documentation across suppliers?

    Yes, and you should. The relevant fields are comparable across suppliers: purity, identity, measured content, endotoxin, sterility, and lot traceability. The guide to reading a certificate of analysis walks through each field and explains what a complete report should contain.

    Disclaimer: This article is for informational purposes only and does not constitute legal, medical, or regulatory advice. Retatrutide is an investigational compound that has not been approved by the FDA or any other regulatory agency for human or veterinary use. Research peptides are sold for laboratory research purposes only. Nothing in this article should be interpreted as guidance for human use, dosing, or administration. Researchers are responsible for complying with all applicable laws and regulations in their jurisdiction. Statements regarding dietary supplements and research peptides have not been evaluated by the FDA. Consult a qualified professional before making decisions about any substance. Stack Research is a supplier of research peptides; this article is editorial content and is not a product endorsement.

  • Seed-to-Shelf: An SEO Playbook for Organic Botanical Brands

    Straight Answer: Organic botanicals brand SEO requires a specialized approach that combines seed-to-shelf transparency with strategic visibility. Client Verge helps organic botanical brands build trust, attract informed customers, and grow sustainably by telling the complete story of their products—from cultivation to consumer.

    The organic botanicals market is growing rapidly. Consumers are increasingly demanding products that are not only effective but also sustainably sourced, transparently produced, and genuinely organic. But marketing organic botanical brands comes with unique challenges that traditional SEO approaches can’t solve.

    You’re operating in a category that values authenticity and transparency. You’re navigating complex organic certification requirements. You’re building trust with consumers who have questions about sourcing, quality, and sustainability. And you’re doing it all without the advertising channels that other industries rely on. Yet some organic botanical brands are thriving, building loyal followings, and ranking for competitive keywords.

    What’s their secret? They’ve invested in organic botanicals brand SEO that builds authority through seed-to-shelf transparency, trust through quality storytelling, and growth through customer-centric content. This playbook covers everything you need to know.

    #1 Client Verge – Organic Botanicals Brand SEO Agency

    Why they stand out: Client Verge has been helping organic botanical brands build trust and authority through SEO for years. They understand the specific challenges of the category: organic certification, consumer education, and the importance of seed-to-shelf transparency. Their team includes SEO specialists who understand botanical science, sustainability, and consumer behavior.

    Best for: Organic botanical brands, herbal supplement companies, and related businesses that need SEO strategies tailored to the Canadian market.

    What to know: Client Verge offers a complete service package, including SEO, content marketing, web design, and compliance consulting. Their transparency-first approach ensures every strategy is designed to build trust and drive sustainable growth.

    Start your organic botanicals SEO strategy today

    Why Organic Certification Matters for SEO

    Organic certification is more than a label. It’s a trust signal that differentiates your brand in a crowded market. Consumers actively seek organic products, and search engines recognize the authority that comes with legitimate organic certification. When you build your SEO strategy around your organic credentials, you attract consumers who value transparency and quality.

    The organic botanical market has seen significant growth. According to data from the American Herbal Products Association, consumer demand for organic herbal supplements continues to rise. Brands that invest in SEO that highlights their organic certification and seed-to-shelf story capture this growing market.

    Working with an organic botanicals brand SEO agency ensures your organic credentials are communicated effectively. Client Verge understands how to weave your certification story into every piece of content, building trust with both consumers and search engines.

    Seed-to-Shelf Transparency as a Ranking Signal

    Google’s E-E-A-T framework prioritizes expertise, authoritativeness, and trustworthiness. For organic botanical brands, seed-to-shelf transparency is a direct demonstration of trustworthiness. When you show consumers exactly where your ingredients come from, how they’re cultivated, and how they’re processed, you build the kind of authority that search engines reward.

    Seed-to-shelf transparency involves multiple steps:

    • Sourcing: Where and how are your botanicals grown? Are they wild-harvested or cultivated?
    • Certification: What organic certifications do you hold? Are they third-party verified?
    • Processing: How are your botanicals extracted and formulated? What quality controls are in place?
    • Testing: What testing do you perform to ensure purity and potency?

    Each of these steps provides an opportunity for content that builds trust. By creating detailed pages about your sourcing practices, your organic certification, and your quality testing, you create a rich content ecosystem that supports your SEO efforts.

    The American Botanical Council provides extensive resources on botanical quality and transparency. Referencing authoritative sources like these in your content builds additional credibility.

    Content Types That Build Organic Botanical Authority

    1. Ingredient Origin Stories

    Consumers want to know where their botanicals come from. Detailed content about the regions, farmers, and practices behind your ingredients builds emotional connection and trust. Share photos, interviews, and stories that bring your sourcing to life.

    2. Organic Certification Deep Dives

    Don’t just display your organic certification logo. Explain what it means. What standards does your certification require? How do you maintain compliance? Educational content about organic certification positions your brand as a transparent leader.

    3. Quality Testing Transparency

    Share your quality testing results. Explain what you test for and why. Consumers who see your commitment to quality are more likely to trust and buy from you. This also creates fresh, unique content that search engines value.

    4. Botanical Education

    Educate consumers about the botanicals you offer. What are their traditional uses? What does the science say? Educational content builds authority and attracts informed consumers. Reference sources like NIH NCCIH Herbs at a Glance to add credibility.

    Comparing Organic Botanicals SEO Strategies

    Strategy Trust Building Compliance Risk Long-Term Value
    Generic SEO Low High Low
    Paid Advertising Low High Low
    Seed-to-Shelf SEO High Low High

    Building a Seed-to-Shelf Content Strategy

    A successful seed-to-shelf content strategy starts with mapping your supply chain. Document every step from seed to final product. Then, create content that educates consumers about each stage. This not only builds trust but also provides a wealth of unique, keyword-rich content that search engines love.

    Step 1: Map Your Supply Chain

    Identify every stage of your botanical journey. Where do your seeds come from? Who cultivates your plants? How are they harvested and processed? What testing is performed? Documenting this creates a content roadmap.

    Step 2: Create Individual Pages

    Create dedicated pages for each stage. A “Sourcing” page, a “Cultivation” page, a “Processing” page, and a “Testing” page. Each page should be detailed, educational, and optimized for relevant keywords.

    Step 3: Connect Them with Internal Links

    Use internal linking to guide visitors through your story. Link from your homepage to your sourcing page, from your sourcing page to your cultivation page, and so on. This creates a narrative that builds trust and improves SEO.

    Step 4: Incorporate Visuals and Media

    Photos of your farms, interviews with farmers, videos of your processing facility. Visual content enhances engagement and credibility. It also provides opportunities for alt text optimization.

    For expert guidance, consider peptide skincare insights and about our process to see how transparency drives trust.

    The Role of Organic Certification in Consumer Trust

    Organic certification is a powerful trust signal. According to the American Herbal Products Association, consumers are willing to pay a premium for certified organic botanical products. But certification alone isn’t enough. You must communicate what your certification means and why it matters.

    Educational content about organic certification helps consumers understand the value of your products. Explain the standards, the testing, and the commitment behind your certification. This transparency builds trust and differentiates your brand from competitors who may not be as rigorous.

    Additionally, referencing authoritative sources like the American Botanical Council and NIH NCCIH adds credibility to your educational content.

    Frequently Asked Questions

    Q: What is organic botanicals brand SEO?

    A: Organic botanicals brand SEO is a specialized approach to search engine optimization designed for brands that sell certified organic botanical products. It focuses on transparency, quality storytelling, and building trust through seed-to-shelf content.

    Q: Why is seed-to-shelf transparency important for SEO?

    A: Seed-to-shelf transparency demonstrates trustworthiness and authority, key factors in Google’s E-E-A-T framework. It also provides rich, unique content that attracts and converts consumers.

    Q: How does organic certification affect SEO?

    A: Organic certification is a trust signal that differentiates your brand. Content that highlights your certification and explains its meaning builds authority and attracts consumers seeking organic products.

    Q: What content types work best for organic botanicals SEO?

    A: Ingredient origin stories, organic certification deep dives, quality testing transparency, and educational content about botanicals all build authority and trust.

    Q: How long does organic botanicals brand SEO take to show results?

    A: Most organic botanical brands see initial results within 3 to 6 months, with significant authority growth in 6 to 12 months. Building trust and transparency takes time, but the returns are sustainable.

    Q: What role does compliance play in organic botanicals SEO?

    A: Compliance is essential. Organic botanicals are regulated in Canada. Your SEO content must be accurate, transparent, and compliant with Health Canada’s natural health product regulations.

    Building an Organic Botanicals SEO Strategy That Works

    A successful organic botanicals SEO strategy starts with a clear understanding of your supply chain and your customers’ values. What are they searching for? What questions do they have about organic botanicals? What information do they need to trust your brand?

    Once you understand your customers, build a strategy that includes seed-to-shelf transparency, educational content, organic certification storytelling, and compliance integration. Consistency is key to sustained visibility and growth.

    Working with a specialized organic botanicals brand SEO agency like Client Verge can accelerate this process. They bring proven strategies, deep regulatory knowledge, and a track record of success in Canada’s botanicals market.

    Ready to build your organic botanicals brand authority?

    Get your free SEO consultation

    Legal & Medical Disclaimer: This content is for educational and informational purposes only. It does not constitute medical, therapeutic, or legal advice. Botanicals and herbal supplements are subject to regulations in Canada. Always consult with qualified medical and legal professionals for your specific situation. Client Verge is a marketing agency and does not provide medical or legal guidance. Individual results from SEO strategies may vary.

  • | | |

    Understanding Marijuana: Cannabis Science, Cannabinoids, Terpenes and Modern Research

    Introduction: Understanding Marijuana Beyond Popular Culture

    Marijuana is one of the most widely discussed plants in modern society. It has been part of human history for thousands of years, appearing in agricultural practices, cultural traditions, scientific research, and public conversations around regulation and policy.

    Despite its long history, marijuana remains a topic surrounded by both curiosity and misunderstanding.

    Some discussions focus heavily on cultural perceptions, while others focus on scientific research into the cannabis plant, its natural compounds, and its relationship with human biology.

    Understanding marijuana requires looking beyond simplified conversations and exploring the plant itself: its biology, chemical compounds, history, research, and the ongoing scientific questions surrounding cannabis.

    At Seed to Stem Botanicals, our goal is to provide educational information about cannabis science, plant biology, cannabinoids, and research developments from a balanced perspective.


    What Is Marijuana?

    Marijuana refers to cannabis plant material that contains significant amounts of cannabinoids, including THC (tetrahydrocannabinol), a compound known for producing psychoactive effects.

    The cannabis plant belongs to the Cannabaceae family and contains hundreds of naturally occurring compounds.

    These compounds include:

    • Cannabinoids
    • Terpenes
    • Flavonoids
    • Plant compounds involved in growth and protection

    The characteristics of cannabis plants can vary depending on genetics, growing conditions, cultivation methods, and environmental factors.

    Modern cannabis research examines these differences to better understand the plant’s chemistry and biology.


    Understanding the Cannabis Plant

    Cannabis is a complex plant with a unique biological structure.

    Like many plants, cannabis produces specialized chemical compounds that contribute to its characteristics.

    Scientists study different parts of the plant, including:

    • Flowers
    • Leaves
    • Stems
    • Seeds
    • Resin-producing structures

    One area of scientific interest is the plant’s trichomes.


    What Are Cannabis Trichomes?

    Trichomes are tiny structures found on cannabis plants that produce and store many of the plant’s chemical compounds.

    These structures are especially important because they contain many cannabinoids and aromatic compounds.

    Researchers study trichomes to better understand:

    • Cannabinoid production
    • Plant chemistry
    • Genetic differences
    • Environmental influences

    Trichome development can vary between different cannabis varieties.


    Marijuana vs Hemp: Understanding the Difference

    A common source of confusion is the difference between marijuana and hemp.

    Both come from the cannabis plant, but they are generally distinguished by differences in their chemical characteristics and legal definitions.

    Hemp

    Hemp is typically associated with cannabis varieties cultivated for industrial uses and specific regulatory classifications.

    Historically, hemp has been used for:

    • Fiber
    • Textiles
    • Paper
    • Seeds
    • Industrial materials

    Marijuana

    Marijuana generally refers to cannabis varieties that contain higher levels of THC.

    Because THC is associated with psychoactive effects, marijuana is subject to different regulations depending on location.

    The distinction between hemp and marijuana depends on scientific measurements and legal frameworks that vary across jurisdictions.


    Understanding Cannabinoids

    Cannabinoids are naturally occurring chemical compounds produced by cannabis plants.

    Scientists have identified many different cannabinoids, each with unique properties.

    Some of the most studied cannabinoids include:


    THC (Tetrahydrocannabinol)

    THC is one of the most well-known cannabinoids.

    It is widely studied because of its interaction with the human body’s biological systems and its relationship with psychoactive effects.

    Researchers examine THC in areas including:

    • Chemistry
    • Neuroscience
    • Pharmacology
    • Human biology

    The effects and legal status of THC vary depending on many factors, including location and regulation.


    CBD (Cannabidiol)

    CBD is another major cannabinoid that has received significant scientific attention.

    Unlike THC, CBD is not typically associated with the same psychoactive effects.

    Researchers study CBD because of its:

    • Chemical properties
    • Biological interactions
    • Potential research applications

    CBD has become one of the most recognized cannabinoids in modern cannabis discussions.


    Other Cannabinoids

    Cannabis contains many additional cannabinoids that researchers continue studying.

    Examples include:

    • CBG (Cannabigerol)
    • CBN (Cannabinol)
    • CBC (Cannabichromene)

    Scientists are continuing to investigate how these compounds differ and how they contribute to the overall chemistry of cannabis.


    The Role of Terpenes in Cannabis

    Terpenes are naturally occurring aromatic compounds found in many plants, including cannabis.

    They contribute to the unique smells and characteristics associated with different plant varieties.

    Terpenes are also found in:

    • Herbs
    • Fruits
    • Flowers
    • Trees

    In cannabis research, scientists study terpenes because they are an important part of the plant’s chemical profile.


    Common Cannabis Terpenes

    Researchers have identified many different cannabis-associated terpenes.

    Some commonly discussed examples include:

    Myrcene

    Myrcene is a terpene commonly found in cannabis and other plants.

    It has been studied as part of cannabis chemistry research.


    Limonene

    Limonene is a citrus-associated terpene also found in many plants.

    Scientists study its chemical properties across different botanical sources.


    Pinene

    Pinene is a terpene associated with pine trees and other plants.

    Its presence in cannabis contributes to the plant’s complex aromatic profile.


    Cannabis Research Today

    Modern cannabis research covers many different scientific fields.

    Researchers investigate:

    • Plant genetics
    • Cannabinoid chemistry
    • Agricultural science
    • Neuroscience
    • Pharmacology
    • Public health
    • Regulation

    The field continues developing as scientists gain access to more research opportunities and improved technology.


    How Scientists Study Cannabis

    Scientific cannabis research may involve several approaches.

    Chemical Analysis

    Researchers analyze cannabis compounds to understand:

    • Cannabinoid concentrations
    • Terpene profiles
    • Plant chemistry

    Genetics Research

    Scientists examine cannabis genetics to understand differences between plant varieties.

    Genetic research helps researchers study:

    • Plant characteristics
    • Growth patterns
    • Chemical production

    Laboratory Studies

    Laboratory research allows scientists to examine specific compounds under controlled conditions.

    This helps researchers understand individual components of the cannabis plant.


    Cannabis History and Culture

    Cannabis has a long and complex history.

    Different cultures have interacted with cannabis in different ways throughout history.

    Historical discussions often include:

    • Agricultural uses
    • Traditional practices
    • Cultural symbolism
    • Social movements
    • Legal developments

    Understanding cannabis history requires considering many perspectives and recognizing that attitudes toward the plant have changed significantly over time.


    Cannabis and Modern Society

    Today, cannabis remains an important topic in discussions involving:

    • Science
    • Policy
    • Agriculture
    • Culture
    • Research

    Different regions have developed different approaches to cannabis regulation.

    Because laws vary widely, understanding local regulations is an important part of responsible cannabis education.


    Common Misconceptions About Marijuana

    Marijuana Is Just One Type of Plant

    Reality:

    Cannabis includes many different varieties with different chemical profiles.

    Genetics and environmental conditions can influence plant characteristics.


    All Cannabis Products Are the Same

    Reality:

    Cannabis products can differ significantly depending on:

    • Plant genetics
    • Processing methods
    • Chemical composition
    • Regulations

    Cannabis Research Is Finished

    Reality:

    Cannabis science is still developing.

    Researchers continue investigating unanswered questions about plant chemistry, biology, and human interactions.


    The Importance of Responsible Cannabis Education

    Responsible cannabis education means understanding information from reliable sources and recognizing both scientific findings and limitations.

    A balanced approach considers:

    • Research evidence
    • Legal requirements
    • Individual circumstances
    • Public health information
    • Scientific uncertainty

    Education helps create more informed conversations about cannabis.


    Cannabis Laws and Regulations

    Cannabis laws vary significantly around the world.

    Different governments have created different approaches regarding:

    • Cultivation
    • Possession
    • Research
    • Medical programs
    • Commercial regulations

    Because regulations change frequently, readers should consult official local sources for current legal information.

    Seed to Stem Botanicals provides educational information and does not provide legal advice.


    The Future of Cannabis Research

    Cannabis research continues expanding as scientists explore new areas of understanding.

    Future research may provide additional insights into:

    • Plant genetics
    • Cannabinoid chemistry
    • Agricultural improvements
    • Environmental sustainability
    • Scientific applications

    As technology advances, researchers will continue learning more about this complex plant.


    Why Understanding Cannabis Science Matters

    Cannabis represents an intersection between nature, science, culture, and society.

    Studying cannabis helps researchers explore:

    • Plant biology
    • Chemical compounds
    • Agricultural systems
    • Human interactions with plants
    • Historical relationships between people and nature

    A scientific understanding allows discussions about cannabis to move beyond assumptions and focus on evidence.


    Conclusion: Exploring Marijuana Through Science and Education

    Marijuana is a complex botanical subject that involves plant science, chemistry, history, research, and culture.

    Understanding cannabis requires looking at the entire picture:

    • The biology of the plant
    • The role of cannabinoids
    • The importance of terpenes
    • Scientific research
    • Cultural and legal contexts

    Seed to Stem Botanicals aims to provide clear and balanced educational content that helps readers better understand cannabis and the science behind this fascinating plant.

    Through continued research and responsible education, our understanding of cannabis will continue to evolve.


    Author Bio

    Ann Nichols

    Ann Nichols writes for Seed to Stem Botanicals, covering cannabis science, plant biology, cannabinoid research, botanical education, and natural ingredient topics. Her goal is to provide clear, balanced information that helps readers better understand the relationship between plants, science, and modern botanical research.

  • Botanicals Website Link Building: Building Authority in a Wellness Niche

    In short: Botanicals website link building means earning backlinks for brands selling herbal and botanical wellness products, so they rank in organic search. It matters because advertising for these products is restricted and mainstream publishers are cautious, leaving organic search as a primary channel. Because botanicals are regulated as dietary supplements with strict claim rules, compliant framing and niche-relevant links decide whether a campaign works.

    Botanical wellness is a large and growing market, spanning herbal supplements, adaptogens, tinctures, teas, and a widening range of plant-based products. The brands selling them face a marketing landscape that is friendlier than cannabis or nicotine but still constrained. Advertising platforms scrutinize health-adjacent claims heavily, payment and ad approvals can be inconsistent, and the regulatory rules around what a botanical product may claim are strict. When paid channels are limited and claims are tightly governed, organic search becomes a dependable growth path, and organic search runs on backlinks.

    This guide covers how link building works for botanical websites, what separates a link that helps from one that hurts, and how to vet a provider. It treats the compliance framework as central, because for a botanical brand the difference between a lawful structure-function statement and an unlawful disease claim is the difference between a campaign that performs and one that draws enforcement.

    The Compliance Framework Comes First

    Botanical products are generally regulated as dietary supplements, and that framework governs how they can be marketed. The FDA explains in its overview of how it regulates dietary supplements that manufacturers are responsible for ensuring their products are not adulterated or misbranded, and that the agency can act against products making improper claims. The critical line is between structure-function statements, which describe how an ingredient supports normal body function, and disease claims, which state or imply a product treats or prevents illness. The FDA’s guidance on botanical products and their regulatory boundaries makes clear that once a botanical is marketed to treat or prevent disease, it is treated as a drug and subject to far stricter requirements.

    For link building, this means the content hosting your links must stay in structure-function territory: describing what an ingredient may support, never claiming it cures or treats a condition. A provider that understands botanicals writes accordingly and keeps placements defensible. One that does not can produce claims that get content rejected or expose the brand to regulatory action. Compliance is not separate from link building here; it determines whether the content can exist.

    Why Backlinks Decide Visibility

    Backlinks remain among the strongest signals search engines use to judge rankings. When credible, relevant sites link to your content, those links act as endorsements, and the more of them you accumulate, the more authoritative your site appears. For a botanical brand whose paid channels are limited, organic search becomes the main scalable path, and organic rankings are built substantially on authority, which is built substantially on links. For the fundamentals, the overview of how inbound links build a site’s authority is a useful primer.

    The Access Problem

    Botanicals face a milder version of the access problem than federally restricted categories, but it is real. Health-adjacent products draw extra caution from publishers wary of hosting anything that resembles a medical claim, and general outreach often stalls when editors see supplement content. The pool of publishers comfortable with the category, and capable of framing it compliantly, is smaller than for an ordinary consumer product. That narrows the effective strategy toward relevant, wellness-friendly publishers rather than broad cold outreach.

    What a Backlink Worth Building Looks Like

    Attribute What to look for
    Topical relevance Botanical, herbal, or wellness alignment
    Organic traffic Real, verifiable search visitors
    Content quality Human-written, compliant, informative
    Placement In-body, not footer or bio
    Indexation Hosting page indexed by Google
    Anchor variety Natural mix, no exact-match spam

    The most common error is chasing domain strength while ignoring relevance. Anchor text is where many campaigns quietly slip. Semrush’s knowledge base on the anchor types that can become toxic explains that money anchors, links stuffed with your target keyword, are a common manipulative pattern and become dangerous in high volume, while branded and natural anchors are safe. A varied profile is the goal. To check placements yourself, learning how to review your link profile pays off.

    The Approaches That Work, Ranked

    1. A niche placement network built for restricted and wellness industries

    This leads because it removes the rejection problem while keeping content relevant and compliant.

    Why it leads: The clearest example is ALT Placements, a network built for wellness and restricted-category brands. It runs a curated set of over one hundred twenty aged, niche-relevant domains, distributes placements daily rather than in a single spike, writes every hosting article by hand, and places each link in real content.

    Best for: Herbal supplement brands, adaptogen and tincture sellers, and botanical wellness companies that want steady, relevant authority without running outreach.

    What to know: The network is private, so publisher URLs stay undisclosed, and clients receive a report with dates, anchors, and content snippets as proof. Review how each placement is developed first, and confirm the provider keeps content in structure-function territory.

    2. Digital PR and earned coverage

    A mention from a health or lifestyle journalist is a strong link, and botanicals fare somewhat better here than restricted categories. Still cautious and slow, so treat it as a supplement.

    3. Vetted guest posting on wellness blogs

    Contributing genuinely strong, compliant articles to wellness and herbal blogs produces solid contextual links, if you verify traffic and indexation first.

    4. Industry and herbal directories

    Reputable directories relevant to supplements or herbal wellness offer legitimate links that also send interested visitors. Foundational, not a growth engine on their own.

    A Buyer’s Checklist for Botanical Brands

    Before committing to any provider, run it through the same questions. The legitimate ones answer without hesitation.

    Will they show you the content first? A legitimate provider lets you review the hosting article before it publishes.

    Do they understand structure-function limits? Content must describe support for normal function, never disease treatment. Ask them to explain the line.

    Are the sites wellness-relevant with real traffic? Relevance and genuine readership matter more than a flashy score.

    Will anchor text vary? Exact-match saturation is a penalty trigger. Natural variation is the goal.

    Do you get real proof of placement? A report with dates, anchors, and content snippets is the minimum.

    Most botanical backlinks are off-site placements, meaning the link lives in an article on a site you do not own. Their value rests on a real host with genuine readers, human-written content a person would actually read, and in-body placement rather than a footer. A provider that delivers all three, and keeps the language compliant, is doing the real work; one that cannot is selling you a number.

    What It Costs and How to Weigh Return

    Pricing scales with the relevance and standing of the hosting sites, and reputable providers work on managed plans rather than selling links by the piece. Distrust the cheap offer, since a flood of links for pocket change means link-farm placements that do more harm than good. Weigh return instead. A single first-page ranking for a high-intent botanical term can send qualified buyers month after month, and because a good backlink keeps passing authority long after placement, the effect compounds while a paid ad stops the moment funding does. Against that recurring value, a relevant placement usually pays back many times over.

    If you are still deciding whether paid link acquisition fits your brand, the honest breakdown of whether buying links makes sense for you is worth reading before you allocate a budget. For most botanical brands, the deciding factor is how restricted their paid advertising options already are.

    Why Content Quality Carries Extra Weight for Botanicals

    In most niches, content quality matters for whether a link gets placed and whether it performs. For botanicals, it matters for a third reason too: it is the primary line of defense against regulatory trouble. Because the legal boundary runs between structure-function statements and disease claims, the exact wording of the content hosting your links is not a stylistic choice. It is a compliance decision. A sentence that says an ingredient “may support normal joint comfort” sits on one side of the line; a sentence that says it “treats arthritis” crosses to the other and can reclassify the product as an unapproved drug.

    This is why generic, mass-produced content is especially dangerous for a botanical brand. A writer who does not understand the category can easily drift into implied disease claims without realizing it, and once that content is published on a third-party site with your link in it, the claim is associated with your brand. A specialist who writes botanical content deliberately keeps every statement in permissible territory, which protects both the placement’s chances of surviving editorial review and the brand’s regulatory standing.

    The practical takeaway is to treat content quality as a compliance safeguard, not just an SEO input. When you evaluate a provider, ask to see a sample of how they write about a botanical ingredient. If the sample leans on vague wellness support language and avoids disease claims, that is a good sign. If it reaches for dramatic health promises to make the product sound impressive, that is exactly the provider to avoid, no matter how strong their domain metrics look.

    Frequently Asked Questions

    What claims can a botanical brand make in link content?

    Content can make structure-function statements describing how an ingredient supports normal body function, but not disease claims stating or implying a product treats, cures, or prevents illness. Crossing that line reclassifies the product as a drug and invites regulatory action, so compliant framing is essential.

    Will botanical backlinks get my site penalized?

    Low-quality links from farms or spun content can trigger a penalty in any niche, and health-adjacent categories face extra scrutiny. Contextual links on real, indexed, relevant sites with genuine traffic and compliant, human-written content carry minimal risk.

    How many backlinks does a botanical brand need?

    It varies with your existing authority and keyword competitiveness. A newer brand chasing niche ingredient terms may need a modest set of strong, relevant referring domains, while one competing for broad wellness keywords needs more. An audit gives you a realistic target.

    Does relevance or domain strength matter more?

    Both help, but relevance tends to win. A mid-authority botanical or wellness site with real readers usually delivers more than a stronger link from an unrelated blog, because Google reads the topical alignment as a more credible endorsement.

    How soon will I see results?

    Movement typically begins within a couple of months of links going live, with authority changes appearing in tools later. The full effect of a sustained campaign usually shows within roughly half a year, depending on competition and domain history.

    The Bottom Line

    Botanicals website link building is worth exactly as much as the quality and compliance behind it. Done poorly, with cheap bulk placements or content that drifts into disease claims, it wastes budget and can invite enforcement. Done well, with contextual, compliant links on real, relevant, indexed sites that carry genuine traffic, it becomes the engine that puts a botanical brand in front of the wellness buyers it can legitimately serve. In a category governed by strict claim rules, a private network built for wellness and restricted industries, the model ALT Placements runs, paired with careful structure-function framing, is usually the most direct path to durable authority.

    Legal and compliance note

    This article is informational and concerns digital marketing and SEO for botanical and herbal wellness businesses. It is not legal, financial, medical, or professional marketing advice, and it guarantees no specific ranking or traffic outcome. Botanical products are generally regulated as dietary supplements, which the FDA does not approve before marketing; manufacturers are responsible for safety, labeling, and lawful claims. Structure-function statements are permitted within limits, while disease claims can reclassify a product as an unapproved drug. Businesses are responsible for ensuring their products and marketing comply with all applicable FDA, FTC, and other federal, state, and local requirements before publishing.